Basket

0556729 - ÚI 2023 RIV NO eng J - Journal Article
Lukáš, M. - Kolář, M. - Reissigová, Jindra - Ďuricová, D. - Machková, N. - Hrubá, V. - Lukáš, M. - Vašátko, M. - Jirsa, J. - Pudilová, K. - Malíčková, K.
A switch from originator-adalimumab to the biosimilar SB5 in patients with Crohn’s disease: an analysis of two propensity score-matched cohorts.
Scandinavian Journal of Gastroenterology. Roč. 57, č. 7 (2022), s. 814-824. ISSN 0036-5521. E-ISSN 1502-7708
Institutional support: RVO:67985807
Keywords : Crohn’s disease * adalimumab * biosimilar
OECD category: Statistics and probability
Impact factor: 1.8, year: 2022
Method of publishing: Open access
http://dx.doi.org/10.1080/00365521.2022.2041082
Permanent Link: http://hdl.handle.net/11104/0330887